Search
Pfizer Completes Acquisition of Metsera
5 day ago /
Read about 0 minute
Author：小编
On November 13 local time, Pfizer Inc. announced that it had successfully completed the acquisition of Metsera. Metsera is a clinical-stage biopharmaceutical company focused on developing next-generation drugs for obesity and cardiovascular-metabolic diseases. On November 7, Pfizer agreed to acquire Metsera for $10 billion, following a fierce bidding war between the company and Novo Nordisk for the acquisition. Ultimately, Metsera announced a revised merger agreement with Pfizer.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
